193 related articles for article (PubMed ID: 27683036)
1. Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.
Petretto A; Carbotti G; Inglese E; Lavarello C; Pistillo MP; Rigo V; Croce M; Longo L; Martini S; Vacca P; Ferrini S; Fabbi M
Oncotarget; 2016 Nov; 7(45):72518-72536. PubMed ID: 27683036
[TBL] [Abstract][Full Text] [Related]
2. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
[TBL] [Abstract][Full Text] [Related]
3. IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
Carbotti G; Barisione G; Airoldi I; Mezzanzanica D; Bagnoli M; Ferrero S; Petretto A; Fabbi M; Ferrini S
Oncotarget; 2015 Dec; 6(41):43267-80. PubMed ID: 26657115
[TBL] [Abstract][Full Text] [Related]
4. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment.
Mimura K; Kua LF; Shiraishi K; Kee Siang L; Shabbir A; Komachi M; Suzuki Y; Nakano T; Yong WP; So J; Kono K
Cancer Sci; 2014 Oct; 105(10):1236-44. PubMed ID: 25154680
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
7. The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies.
Rolvering C; Zimmer AD; Ginolhac A; Margue C; Kirchmeyer M; Servais F; Hermanns HM; Hergovits S; Nazarov PV; Nicot N; Kreis S; Haan S; Behrmann I; Haan C
J Leukoc Biol; 2018 Nov; 104(5):969-985. PubMed ID: 30040142
[TBL] [Abstract][Full Text] [Related]
8. IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-γ release by autologous NK cells.
Morandi F; Airoldi I; Pistoia V
J Immunol Res; 2014; 2014():938561. PubMed ID: 24741633
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells.
Liang YH; Chen KH; Tsai JH; Cheng YM; Lee CC; Kao CH; Chan KY; Chen YT; Hsu WL; Yeh KH
J Biomed Sci; 2021 Nov; 28(1):75. PubMed ID: 34758826
[TBL] [Abstract][Full Text] [Related]
10. An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens.
Olsson N; Heberling ML; Zhang L; Jhunjhunwala S; Phung QT; Lin S; Anania VG; Lill JR; Elias JE
Front Immunol; 2021; 12():662443. PubMed ID: 33936100
[TBL] [Abstract][Full Text] [Related]
11. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma.
Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP
Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818
[TBL] [Abstract][Full Text] [Related]
12. The IL-18 antagonist IL-18-binding protein is produced in the human ovarian cancer microenvironment.
Carbotti G; Barisione G; Orengo AM; Brizzolara A; Airoldi I; Bagnoli M; Pinciroli P; Mezzanzanica D; Centurioni MG; Fabbi M; Ferrini S
Clin Cancer Res; 2013 Sep; 19(17):4611-20. PubMed ID: 23873689
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
14. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
[TBL] [Abstract][Full Text] [Related]
15. IL-12 regulates B7-H1 expression in ovarian cancer-associated macrophages by effects on NF-κB signalling.
Xiong HY; Ma TT; Wu BT; Lin Y; Tu ZG
Asian Pac J Cancer Prev; 2014; 15(14):5767-72. PubMed ID: 25081699
[TBL] [Abstract][Full Text] [Related]
16. Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling.
Marijt KA; Sluijter M; Blijleven L; Tolmeijer SH; Scheeren FA; van der Burg SH; van Hall T
J Immunother Cancer; 2019 Jun; 7(1):152. PubMed ID: 31196219
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
19. IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway.
Zhang Z; Zhou B; Zhang K; Song Y; Zhang L; Xi M
Mol Immunol; 2016 Oct; 78():155-163. PubMed ID: 27639718
[TBL] [Abstract][Full Text] [Related]
20. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
